Atuzaginstat

DB19030InvestigationalSmall molecule

Atuzaginstat is under investigation in clinical trial NCT03823404 (GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease).

Chemical structure of Atuzaginstat
Formula / weight
C19H25F3N2O3 · 386.415 g/mol (avg)
Also known as
Cyclopentanecarboxamide, n-((1s)-5-amino-1-(2-(2,3,6-trifluorophenoxy)acetyl)pentyl)- · N-((3s)-7-amino-2-oxo-1-(2,3,6- trifluorophenoxy)heptan-3-yl)cyclopentanecarboxamide
Code names
COR-388

Resolves to

Compound
UNIIDGN7ROZ8ENCAS2211981-76-7ChEMBLCHEMBL5095230
Structure
InChIKeyOLIMBXKACVCIMM-HNNXBMFYSA-NSMILESNCCCC[C@H](NC(=O)C1CCCC1)C(=O)COC1=C(F)C=CC(F)=C1F

What you can answer from here — as of April 23, 2025

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Atuzaginstat, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In